CAMBRIDGE, Mass., Nov. 11 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its corporate presentation at Credit Suisse First Boston’s Health Care Conference in Phoenix, Arizona. Ian Smith, Vertex’s Senior Vice President and Chief Financial Officer, will deliver the presentation on Wednesday, November 16, 2005 at 8:30 a.m. MST (10:30 a.m. EST).
The presentation will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcast will also be available on the Company’s website until November 30, 2005. To access the webcast, go to Vertex’s website and select the ‘2005 Credit Suisse First Boston’s Health Care Conference’ from the ‘Events Calendar.’ To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations at Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html /
